Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma

Quentin Odom-Lewis, Samantha L. Davis, Stephan Pieper, Shannon M. R. Legge, Emilia F. A. Regenfuss, Nicolas Fernandez, Phillip D. Michaels, João A. Paulo, Steven P. Gygi, Chen Chu, Shanshan Zheng, Paola Dal Cin, Jason L. Hornick, Nicole L. Solimini, Timothy B. Branigan, Mohamed Alyousef, Emanuele Mazzola, Ewa T. Sicinska, Karen Bui, Prafulla C. Gokhale, Christopher A. French, George D. Demetri, Geoffrey I. Shapiro, Inga-Marie Schaefer

Open source

DOI
10.1038/s43856-026-01956-1
Published
2026-10-07
Container
Communications Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s43856-026-01956-1,
  title = {Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma},
  author = {Quentin Odom-Lewis and Samantha L. Davis and Stephan Pieper and Shannon M. R. Legge and Emilia F. A. Regenfuss and Nicolas Fernandez and Phillip D. Michaels and João A. Paulo and Steven P. Gygi and Chen Chu and Shanshan Zheng and Paola Dal Cin and Jason L. Hornick and Nicole L. Solimini and Timothy B. Branigan and Mohamed Alyousef and Emanuele Mazzola and Ewa T. Sicinska and Karen Bui and Prafulla C. Gokhale and Christopher A. French and George D. Demetri and Geoffrey I. Shapiro and Inga-Marie Schaefer},
  year = {2026},
  journal = {Communications Medicine},
  doi = {10.1038/s43856-026-01956-1},
  url = {https://doi.org/10.1038/s43856-026-01956-1}
}

RIS

TY  - JOUR
TI  - Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma
AU  - Quentin Odom-Lewis
AU  - Samantha L. Davis
AU  - Stephan Pieper
AU  - Shannon M. R. Legge
AU  - Emilia F. A. Regenfuss
AU  - Nicolas Fernandez
AU  - Phillip D. Michaels
AU  - João A. Paulo
AU  - Steven P. Gygi
AU  - Chen Chu
AU  - Shanshan Zheng
AU  - Paola Dal Cin
AU  - Jason L. Hornick
AU  - Nicole L. Solimini
AU  - Timothy B. Branigan
AU  - Mohamed Alyousef
AU  - Emanuele Mazzola
AU  - Ewa T. Sicinska
AU  - Karen Bui
AU  - Prafulla C. Gokhale
AU  - Christopher A. French
AU  - George D. Demetri
AU  - Geoffrey I. Shapiro
AU  - Inga-Marie Schaefer
PY  - 2026
JO  - Communications Medicine
DO  - 10.1038/s43856-026-01956-1
UR  - https://doi.org/10.1038/s43856-026-01956-1
ER  - 

APA

Odom-Lewis, Q., Davis, S. L., Pieper, S., Legge, S. M. R., Regenfuss, E. F. A., Fernandez, N., Michaels, P. D., Paulo, J. A., Gygi, S. P., Chu, C., Zheng, S., Cin, P. D., Hornick, J. L., Solimini, N. L., Branigan, T. B., Alyousef, M., Mazzola, E., Sicinska, E. T., Bui, K., Gokhale, P. C., French, C. A., Demetri, G. D., Shapiro, G. I., & Schaefer, I. (2026). Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma. Communications Medicine. https://doi.org/10.1038/s43856-026-01956-1

Source records